Work

A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia

Year: 2019

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.10.018

Authors: Benjamin K. Tomlinson, Molly M. Gallogly, Donna M. Kane, Leland Metheny, Hillard M. Lazarus, Basem M. William, Michael D. Craig, Mark J. Levis, Brenda W. Cooper

Institutions: University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, West Virginia University, West Virginia University Hospitals, Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Astellas Pharma US, Novartis, National Cancer Institute

Award: Case Comprehensive Cancer Center Support Grant

OpenAlex ID: W2983087178

FWCI: 2.296

Cites: 36

Cited by: 27

Related to: 10